Treatment of low-risk myelodysplastic syndromes with high-dose daily oral cholecalciferol (2000-4000 IU vitamin D(3)).

Source:http://linkedlifedata.com/resource/pubmed/id/17344922

Download in:

View as

General Info

PMID
17344922